# Effect of Addition of Aromatase Inhibitor to Ovarian Stimulation Therapy in IVF Treatment

> **NCT02946684** · PHASE2,PHASE3 · COMPLETED · sponsor: **Sven O. Skouby** · enrollment: 129 (actual)

## Conditions studied

- Infertility

## Interventions

- **DRUG:** Letrozole
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02946684
- **Lead sponsor:** Sven O. Skouby
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-02-01
- **Primary completion:** 2018-10-30
- **Final completion:** 2018-10-30
- **Target enrollment:** 129 (ACTUAL)
- **Last updated:** 2019-07-08

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02946684

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02946684, "Effect of Addition of Aromatase Inhibitor to Ovarian Stimulation Therapy in IVF Treatment". Retrieved via AI Analytics 2026-06-15 from https://api.ai-analytics.org/clinical/NCT02946684. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*